Archean Chemical IPO: Should you bet on this marine chemical player despite pricey valuations?
Based on FY22 earnings, the company is valued at 26.5x P/E, 12.4x EV/EBITDA and 5.1x EV/Sales, which is a discount to peers. The company has a leading market position and it is undergoing continued expansion, said Reliance Securities.
